In this vein, PARP1 antagonists have been shown to markedly suppress inflammatory indices in TBI rat paradigms (d’Avila et al., 2012) and in a model of localized aseptic meningitis (Rom et al., 2016). This evidence concerns the gene PARP1 and aseptic meningitis.